Griseofulvin: Mechanisms, Evidence, and Best Practices as a Microtubule-Associated Inhibitor

Executive Summary: Griseofulvin (CAS No. 126-07-8) is a microtubule-associated inhibitor that disrupts fungal cell mitosis, enabling its use as an antifungal research agent (APExBIO Griseofulvin). It acts by interfering with microtubule dynamics, leading to cell cycle arrest in susceptible fungal species (Bernacki et al., 2019). The compound is insoluble in water and ethanol, but dissolves in DMSO at concentrations ≥10.45 mg/mL, with optimal storage at -20°C for chemical stability. Purity is confirmed at approximately 98% by HPLC and NMR. Griseofulvin is not approved for clinical or diagnostic use and is recommended strictly for scientific research (APExBIO).

Biological Rationale

Griseofulvin has long been recognized as an antifungal agent for fungal infection research. Its biological utility arises from its capacity to inhibit fungal cell division by targeting microtubule function (Bernacki et al., 2019). Microtubules are essential for mitotic spindle formation and chromosome segregation in eukaryotic cells. Disruption of microtubule dynamics impairs mitosis, leading to cell cycle arrest and inhibition of fungal proliferation. The specificity of Griseofulvin’s action on fungal microtubules, as opposed to mammalian, has enabled its use in several fungal disease models and cytoskeletal research workflows. The compound’s mechanism of action aligns it with other spindle poisons, but its selective activity has made it a canonical tool in mycology and cellular biology (see related review).

Mechanism of Action of Griseofulvin

Griseofulvin binds to microtubule proteins, destabilizing microtubule assembly and interfering with the dynamic polymerization and depolymerization cycles necessary for mitosis (Bernacki et al., 2019). The result is a failure to form a functional mitotic spindle, which arrests cells at metaphase and prevents normal chromosome segregation. In fungal pathogens, this leads to inhibition of growth and colony formation. Molecular studies have confirmed that Griseofulvin's impact on microtubule dynamics is dose-dependent and reversible upon compound withdrawal. The compound does not significantly inhibit mammalian microtubules at concentrations used for antifungal research (further mechanistic details), which reduces off-target cytotoxicity in mammalian cell models.

Evidence & Benchmarks

• Griseofulvin was shown to destabilize microtubules in TK6 cell-based aneugenicity assays, reducing 488 Taxol-associated fluorescence and increasing rates of mitotic arrest (Bernacki et al., 2019).
• Purity of APExBIO Griseofulvin is confirmed at ~98% via HPLC and NMR under standard laboratory conditions (APExBIO).
• In vitro, Griseofulvin achieves complete solubilization in DMSO at concentrations ≥10.45 mg/mL at room temperature (APExBIO).
• Product stability is optimal when stored at -20°C; solutions are not recommended for long-term storage due to observed degradation (APExBIO).
• Benchmark studies show Griseofulvin-induced cell cycle arrest at metaphase is reversible and does not induce clastogenic effects in standard assays (Bernacki et al., 2019).

This article extends the findings of 'Griseofulvin as a Microtubule-Associated Inhibitor: Mechanistic Evidence and Strategy' by providing updated quantitative solubility, purity, and storage parameters validated for current research workflows.

Applications, Limits & Misconceptions

Griseofulvin is primarily used as an antifungal compound for cell culture, fungal infection model development, and studies of microtubule dynamics pathways. It is a preferred agent in fungal mitosis inhibition screens and as a tool compound for elucidating the mechanisms of cell cycle arrest. In the context of drug discovery, Griseofulvin aids in benchmarking new antifungal candidates against a well-characterized reference inhibitor.

Common Pitfalls or Misconceptions

• Griseofulvin is not suitable for clinical or diagnostic use; it is strictly for scientific research (APExBIO).
• It does not act as a broad-spectrum cytoskeleton inhibitor in mammalian cells at antifungal-relevant concentrations (Bernacki et al., 2019).
• Long-term storage of Griseofulvin solutions is not recommended due to chemical instability; degradation may confound experimental results (APExBIO).
• Griseofulvin is ineffective against non-microtubule-dependent pathogens or bacteria.
• Conflation with other microtubule inhibitors (e.g., Taxol) is incorrect; Griseofulvin destabilizes, not stabilizes, microtubules (Bernacki et al., 2019).

This article clarifies boundaries of use, expanding on the molecular specificity discussed in 'Griseofulvin and the Microtubule Frontier', by detailing storage and solubility conditions relevant to reproducible research.

Workflow Integration & Parameters

For experimental use, Griseofulvin powder should be dissolved in DMSO to prepare concentrated stock solutions (≥10.45 mg/mL). Stocks must be aliquoted to minimize freeze-thaw cycles and stored at -20°C. Working solutions should be prepared fresh prior to use. Griseofulvin is compatible with standard cell culture models and fungal infection assays. For microtubule dynamics studies, concentration-response protocols are recommended, with controls for DMSO vehicle effects. Benchmarking against other microtubule inhibitors is advised for mechanistic validation. Product purity (98%, HPLC/NMR) ensures reproducibility in comparative studies (APExBIO Griseofulvin B3680 kit).

This article updates the workflow strategies outlined in 'Griseofulvin and the Transformation of Antifungal and Aneugenicity Research' by concretely specifying DMSO solubilization and storage-at-temperature parameters.

Conclusion & Outlook

Griseofulvin remains a foundational research tool for dissecting microtubule dynamics and fungal cell cycle control. Its validated mechanism and high chemical purity support its continued use in antifungal agent discovery and microtubule pathway analysis. Advances in molecular assays and machine learning-based target prediction further refine its application in aneugenicity profiling (Bernacki et al., 2019). For reliable results, strict adherence to recommended storage, solubilization, and workflow protocols is essential. APExBIO offers research-grade Griseofulvin (SKU: B3680) for these specialized applications (product details).